Expression systems for therapeutic glycoprotein production.
about
Fc glycans of therapeutic antibodies as critical quality attributesRecent advances in mammalian protein productionLanthanide binding and IgG affinity construct: Potential applications in solution NMR, MRI, and luminescence microscopyStructural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16Low level sequence variant analysis of recombinant proteins: an optimized approachIn situ monitoring of intracellular glucose and glutamine in CHO cell cultureA single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferretsA rapid Flp-In system for expression of secreted H5N1 influenza hemagglutinin vaccine immunogen in mammalian cellsN-Glycan Modification of a Recombinant Protein via Coexpression of Human Glycosyltransferases in Silkworm Pupae.Regulation of apoptosis through bcl-2/bax proteins expression and DNA damage by nano-sized gadolinium oxide.Identification of a novel temperature sensitive promoter in CHO cells.High-throughput sorting of the highest producing cell via a transiently protein-anchored systemGenome-scale metabolic reconstruction and in silico analysis of methylotrophic yeast Pichia pastoris for strain improvementHuman extracellular superoxide dismutase (EC-SOD) expression in transgenic chickenHost cell protein dynamics in the supernatant of a mAb producing CHO cell line.Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins.A novel bifunctional protein TNFR2-Fc-IL-1ra (TFI): expression, purification and its neutralization activity of inflammatory factors.A multi-omics analysis of recombinant protein production in Hek293 cells.Quantitative correlation between transcriptional levels of ER chaperone, peroximal protein and FVIII productivity in human Hek-293 cell lineA library of functional recombinant cell-surface and secreted P. falciparum merozoite proteins.In vivo crystallization of human IgG in the endoplasmic reticulum of engineered Chinese hamster ovary (CHO) cells.High-throughput glycosylation analysis of therapeutic immunoglobulin G by capillary gel electrophoresis using a DNA analyzerAnalyzing clonal variation of monoclonal antibody-producing CHO cell lines using an in silico metabolomic platformMass spectrometric analysis of products of metabolic glycan engineering with azido-modification of sialic acids.Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women.Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methodsGlycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin.Impact of a human CMP-sialic acid transporter on recombinant glycoprotein sialylation in glycoengineered insect cells.Moss-made pharmaceuticals: from bench to bedside.Simple piggyBac transposon-based mammalian cell expression system for inducible protein production.Use of transgenic animals in biotechnology: prospects and problems.The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth.Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives.Oxidative stress in fungal fermentation processes: the roles of alternative respiration.Increasing recombinant protein production in Escherichia coli through metabolic and genetic engineering.Use of a Plackett-Burman statistical design to determine the effect of selected amino acids on monoclonal antibody production in CHO cells.Glycoprotein production in moss bioreactors.Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation.Glycopeptide enrichment and separation for protein glycosylation analysis.
P2860
Q26799266-A6AB9587-7E18-453F-B85C-BD4A5F3DFBC0Q27008285-6E104131-5083-44C0-8F41-B4F7901B237FQ27671018-04949B2A-3A23-4E07-82A7-FF590B62D3F5Q27678312-EAF6CC7B-3D4D-47A4-9D12-CA2BB33050BCQ28727418-7F7B204D-48EF-4FC2-8C6C-9B80B25E218CQ28730784-AC1C6780-3D3C-4F97-9E0A-D56784916283Q28752179-D13FEBC7-CAED-4B03-BC64-26FADB31A066Q30392305-0A52E8FB-2B3D-4F9D-AFEE-705B47322E6AQ30400550-9F988AB4-6771-48A3-A111-77C3481E61A6Q33684020-5BC055FA-4A4C-4544-BFC3-C9200368E961Q33838197-1098CD49-6D9C-404E-90C5-F6998F8CA12EQ33898938-B0DC97C4-4F94-48C2-88A0-B3B203491B25Q33921385-7186AB8E-876B-44FD-BFD2-273A84156F17Q34013904-288E1490-77BA-4A13-844E-B471CD2AAF9EQ34049531-B43CA454-5D46-44F6-863A-4750D736CDCFQ34085446-036CCF4F-507F-49CF-9392-919EBBC80A37Q34127850-5A76D390-24A5-43EA-8205-BE79AE61CEC4Q34261113-98D7712A-B2B5-46B3-9613-9AA878C51DCAQ34399137-4F5A4522-BD57-425E-82D0-605C5E76E6AEQ34629632-8C910A17-8111-4D03-8747-FF17BABF393FQ34991300-22092E6A-273B-482C-B1CA-3AE2B50752B3Q35011096-01111CEB-B019-4068-A57D-57FE7E381022Q35019925-B2C01894-42F5-4ACF-A7AA-1A970F6EF876Q35121927-BE8A297E-C07D-4927-9A67-63D08AF821BBQ35771248-C4C11AAB-24D5-4B75-975A-34BBA79B71ECQ35871759-CD9A98CE-031D-4FC1-B6C3-BA553470DD40Q36216323-DEB928FE-8BD0-4E64-A835-44D7DE3C0F03Q36363190-EBCD80D9-7768-44BB-86A3-87CCF4DF1B52Q36491777-EB0EBA4F-27ED-40BB-8AAF-2C292A4829CCQ36530505-A47E0794-544B-444B-B3B7-5D8889F0C875Q36729772-DD9951C1-EF86-4B40-8EF4-7E62509EF43BQ36730328-D6869D02-CDA6-4241-81D3-FCC598A85A72Q37355646-B21C2C58-2271-4315-9100-203B5D287B06Q37494846-1223C630-A2BF-4697-A99D-41CB7F890838Q37810798-56BA2ECC-7D11-42E4-9671-BFAB53633895Q37928986-791490AA-4926-4AB7-B6EE-C8BA4DF97241Q37929098-B1965E2E-7633-4926-B557-343ED38AF411Q37940883-F3F3BB62-8C3F-43E8-81AF-EB764C5A3A94Q38012151-2B734FAB-DB13-46D3-B5B9-4C2E75D04D7DQ38045258-6586EC62-36E7-4F64-871C-2EEE2F1F45CE
P2860
Expression systems for therapeutic glycoprotein production.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Expression systems for therapeutic glycoprotein production.
@en
Expression systems for therapeutic glycoprotein production.
@nl
type
label
Expression systems for therapeutic glycoprotein production.
@en
Expression systems for therapeutic glycoprotein production.
@nl
prefLabel
Expression systems for therapeutic glycoprotein production.
@en
Expression systems for therapeutic glycoprotein production.
@nl
P1476
Expression systems for therapeutic glycoprotein production
@en
P2093
Yves Durocher
P304
P356
10.1016/J.COPBIO.2009.10.008
P577
2009-11-04T00:00:00Z